Market Overview

Coherus Biosciences (NASDAQ: CHRS)

18.49 -0.76 (-3.95%)

Earnings

QuarterPriorEstimateActualSurprise
Q3 2020
After-Hours
EPS:
REV:
0.63
111.684M



Q2 2020
After-Hours
EPS:
REV:




Q1 2020
After-Hours
EPS:
REV:
-0.29
37.098M



Q4 2019
After-Hours
EPS:
REV:
-0.92



Q3 2019
After-Hours
EPS:
REV:
-0.87
0.51
101.37M
0.63
111.684M
23.53%
10.17%
Q2 2019
After-Hours
EPS:
REV:
-0.68
0
0.08
75.49M
0.32
83.433M
300%
10.52%
Q1 2019
After-Hours
EPS:
REV:
-0.74
0
-0.46
37.05M
-0.29
37.098M
36.96%
0.13%
Q4 2018
After-Hours
EPS:
REV:
-0.84
-0.86
-0.92
6.98%
Q3 2018
After-Hours
EPS:
REV:
-1.09
-0.77
-0.87
12.99%
Q2 2018
After-Hours
EPS:
REV:
-1.08
1.395M
-0.64
-0.68
6.25%

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!